Avanos Medical (AVNS) Shares Outstanding (Weighted Average) (2013 - 2026)

Avanos Medical has disclosed Shares Outstanding (Weighted Average) across 14 years of filings, most recently posting $46.5 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $46.5 million, up 0.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.5 million (up 0.87% YoY), and the FY2025 annual result was $46.3 million, up 0.65% from the prior year.
• Shares Outstanding (Weighted Average) came in at $46.5 million for Q1 2026 at Avanos Medical, roughly flat from $46.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $47.4 million in Q1 2022 to a low of $45.9 million in Q2 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $46.5 million (2026), against an average of $46.5 million.
• Across the five-year window, Shares Outstanding (Weighted Average) retreated 3.12% in 2022 and grew 0.87% in 2025, its largest moves.
• Avanos Medical's Shares Outstanding (Weighted Average) stood at $46.9 million in 2022, then fell by 0.64% to $46.6 million in 2023, then declined by 1.29% to $46.0 million in 2024, then increased by 0.65% to $46.3 million in 2025, then advanced by 0.43% to $46.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $46.5 million (Q1 2026), $46.3 million (Q4 2025), and $46.3 million (Q3 2025), per Business Quant data.